, Volume 42, Issue 5, pp 945–946 | Cite as

Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization



Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.


  1. 1.
    Vodovar D, Marcade G, Rousseau H, Raskine L, Vicaut E, Deye N, et al. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization. Infection. 2014;42(4):743–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Razazi K, Derde LP, Verachten M, Legrand P, Lesprit P, Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria in the intensive care unit. Intensive Care Med. 2012;38(11):1769–78.PubMedCrossRefGoogle Scholar
  3. 3.
    Goulenok T, Ferroni A, Bille E, Lecuyer H, Join-Lambert O, Descamps P, et al. Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization? J Hosp Infec. 2013;84(4):294–9.CrossRefGoogle Scholar
  4. 4.
    Leistner R, Meyer E, Gastmeier P, Pfeifer Y, Eller C, Dem P, et al. Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia Coli. an exploratory case-control study. PLoS ONE. 2013;8(9):e74323.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Geffers C, Gastmeier P. Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System). Deutsches Arzteblatt Intern. 2011;108(6):87–93.Google Scholar
  6. 6.
    Valenza G, Nickel S, Pfeifer Y, Eller C, Krupa E, Lehner-Reindl V, et al. Extended-spectrum-beta-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother. 2014;58(2):1228–30.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Critical care (London, England). 2010;14(3):R113.Google Scholar
  8. 8.
    Al-Qas Hanna F, Sambirska O, Iyer S, Szpunar S, Fakih MG. Clinician practice and the National Healthcare Safety Network definition for the diagnosis of catheter-associated urinary tract infection. Am J Infec control. 2013;41(12):1173–7.Google Scholar
  9. 9.
    Kola A, Schwab F, Barwolff S, Eckmanns T, Weist K, Dinger E, et al. Is there an association between nosocomial infection rates and bacterial cross transmissions? Crit Care Med. 2010;38(1):46–50.PubMedCrossRefGoogle Scholar
  10. 10.
    Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, et al. Targeted versus universal decolonization to prevent ICU infection. The New England J Med. 2013;368(24):2255–65.CrossRefGoogle Scholar
  11. 11.
    Oostdijk EA, de Smet AM, Kesecioglu J, Bonten MJ. Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units. J antimicrob chemother. 2012;67(9):2250–3.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Institute of Hygiene and Environmental MedicineCharité UniversitätsmedizinBerlinGermany
  2. 2.National Reference Center for Surveillance of Nosocomial Infections, Chartié UniversitätsmedizinBerlinGermany

Personalised recommendations